| Identification | |
| Name: | Pregna-1,4-diene-3,20-dione,21-chloro-6,9-difluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)-, (6a,11b,16b)- |
| Synonyms: | BMY30056;CGP 14458;Miracorten;Ulobetasol propionate;Ultravate; |
| CAS: | 66852-54-8 |
| Molecular Formula: | C25H31ClF2O5 |
| Molecular Weight: | 484.96 |
| InChI: | InChI=1/C25H31ClF2O5/c1-5-21(32)33-25(20(31)12-26)13(2)8-15-16-10-18(27)17-9-14(29)6-7-22(17,3)24(16,28)19(30)11-23(15,25)4/h6-7,9,13,15-16,18-19,30H,5,8,10-12H2,1-4H3/t13-,15?,16?,18-,19?,22?,23?,24-,25-/m0/s1 |
| Molecular Structure: |  |
| Properties | |
| Melting Point: | 220 - 221 |
| Density: | 1.31 g/cm3 |
| Stability: | stable at normal temperatures and pressures. |
| Refractive index: | 1.551 |
| Solubility: | Insoluble |
| Appearance: | Distributed as 0.05% ointment. |
| Storage Temperature: | Product should be stored in cool, dry place, away from sources of heat. Store between 15 and 30 C. |
| Usage: | Topical corticosteroid. |
| Safety Data | |
 |
|
